WEE1 and head and neck squamous cell carcinoma: The Wee1i AZD1775 combined with cisplatin can synergistically inhibit the proliferation and survival of cisplatin-resistant HNSCC cells by inducing DNA damage and apoptosis, suggesting that Wee1 inhibition can improve the efficacy of cisplatin-resistant HNSCC (126).